Statistics for ORIC Pharmaceuticals (id:8203 ORIC)
Valuation metrics
Market cap
723.77M
Enterprise value
449.92M
Trailing P/E (ttm)
-4.89
Forward P/E
-5.05
PEG ratio
-5.05
Price/Sales (ttm)
Price/Book (mrq)
2.30
Enterprise Value/Revenue
Enterprise Value/EBITDA
-3.63
Overview
Shares outstanding
70.54M
Float
42.72M
Shares short
12.00M
% Held by insiders
0.09%
% Held by institutions
0.99%
Average volume (10 days)
455.01K
Average volume (90 days)
Price summary
52-Week low
6.33
52-Week high
16.65
52-Week change
23.15%
Beta
1.12
50-Day moving average
9.71
200-Day moving average
10.18
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-25.20%
Return on equity
-38.79%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-124,064,000.00
Net income to common (ttm)
-110,782,000.00
Diluted EPS (ttm)
-1.76
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
286.41M
Total cash per share (mrq)
4.06
Total debt (mrq)
9.74M
Total Debt/Equity (mrq)
3.22
Current ratio (mrq)
1.51K%
Book value per share (mrq)
4.47
Cash flow
Cash flow statement
-99,726,000.00
Levered free cash flow (LFCF)
-59,144,124.00